News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Guided Therapeutics, Inc. Awarded Third Year Funding of National Cancer Institute Grant for LuViva(TM) Advanced Cervical Scan


8/25/2011 9:49:42 AM

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it was awarded $517,000 to fund the third year of a $2.5 million three-year grant from the National Cancer Institute (NCI). The grant provides additional resources to help commercialize and bring to market the LuViva™ Advanced Cervical Scan and Cervical Guide single-patient-use disposable. LuViva is currently under pre-market approval (PMA) review by the U.S. Food and Drug Administration.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES